Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 5, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, March 4, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Lewis Maintained (ZBH) at Buy with Increased Target to $143 on, Mar 4th, 2019
David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Increased Target from $132 to $143 on, Mar 4th, 2019.
David has made no other calls on ZBH in the last 4 months.
There are 3 other peers that have a rating on ZBH. Out of the 3 peers that are also analyzing ZBH, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kristen Stewart of "Deutsche Bank" Initiated at Hold and Held Target at $108 on, Thursday, January 3rd, 2019
These are the ratings of the 2 analyists that currently disagree with David
- Amit Hazan of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $127 on, Wednesday, January 2nd, 2019
- Matthew Taylor of "UBS" Initiated at Strong Buy and Held Target at $140 on, Wednesday, November 28th, 2018
